What Doctors Really Think of GLP-1 Medications

It seems like the most popular medication in the world right now is Ozempic (semaglutide). In the United States, where 36 million people have type 2 diabetes, doctors, scientists and investors are waiting to see which medication will come out on top. Deerfield Institute, a division of Deerfield Management Company, surveyed endocrinologists about their view of the GLP-1 landscape. Cure's whitepaper reports the survey's findings publicly for the first time. Download to read more.